Other Assets, Current in USD of Emmaus Life Sciences, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Emmaus Life Sciences, Inc. quarterly Other Assets, Current history and change rate from Q4 2018 to Q3 2025.
  • Emmaus Life Sciences, Inc. Other Assets, Current for the quarter ending 30 Sep 2025 was $315K, a 61.4% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $315K -$502K -61.4% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $220K -$434K -66.4% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $211K -$551K -72.3% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $226K -$370K -62.1% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $817K +$170K +26.3% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $654K +$220K +50.7% 30 Jun 2024 10-Q 10 Sep 2024
Q1 2024 $762K +$361K +90% 31 Mar 2024 10-Q 10 Sep 2024
Q4 2023 $596K +$147K +32.7% 31 Dec 2023 10-K 14 Apr 2025
Q3 2023 $647K +$136K +26.6% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $434K +$12K +2.84% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $401K +$22K +5.81% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $449K +$55K +14% 31 Dec 2022 10-K 03 Jul 2024
Q3 2022 $511K +$261K +104% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $422K +$151K +55.7% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $379K +$142K +59.9% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $394K -$249K -38.7% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $250K -$322K -56.3% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $271K -$628K -69.9% 30 Jun 2021 10-Q 01 Sep 2021
Q1 2021 $237K -$412K -63.5% 31 Mar 2021 10-Q 01 Sep 2021
Q4 2020 $643K -$24K -3.6% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $572K -$195K -25.4% 30 Sep 2020 10-Q 26 Aug 2021
Q2 2020 $899K +$287K +46.9% 30 Jun 2020 10-Q 26 Aug 2021
Q1 2020 $649K 31 Mar 2020 10-Q 26 Aug 2021
Q4 2019 $667K +$256K +62.3% 31 Dec 2019 10-Q 26 Aug 2021
Q3 2019 $767K 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 $612K 30 Jun 2019 8-K/A 14 Aug 2019
Q4 2018 $411K 31 Dec 2018 10-K 25 Jan 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.